Results 151 to 160 of about 209,106 (262)
Integration of Nanotechnology with ctDNA: New Advances for Monitoring Neoadjuvant Chemotherapy. [PDF]
Wang Y, Kong J, Tian R.
europepmc +1 more source
ABSTRACT In this study, we identified gene modules and representative candidate biomarkers linked to clinical progression in patients with UBC. Weighted gene co‐expression network analysis (WGCNA) was used to identify gene modules associated with TNM staging in UBC patients.
Arshia Azmoudeh
wiley +1 more source
Global Perspectives on Radiotherapy Utilization for Pancreatic Ductal Adenocarcinoma. [PDF]
Reames BN +7 more
europepmc +1 more source
Bing-Lei Ma,1,2,* Lin Yao,1,2,* Yu Fan,1,2 Yu Wang,1,2 Yi-Sen Meng,1,2 Qian Zhang,1,2 Zhi-Song He,1,2 Jie Jin,1,2 Li-Qun Zhou1,21Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, Beijing, People’s ...
Yao L +8 more
core
This graphical abstract summarizes the post‐pCR clinical pathway in locally advanced rectal cancer. After neoadjuvant radiotherapy and systemic therapy followed by surgery, patients achieving pCR (ypT0N0) generally have durable disease control, although residual risks of local and distant recurrence remain. Risk assessment, guideline‐based surveillance,
Jia‐ang Wang +3 more
wiley +1 more source
Pregnancy‐associated breast cancer (PrBC) presents therapeutic challenges. Understanding maternal–fetal safety of systemic anticancer therapies is critical. We performed a case/non‐case disproportionality analysis using the WHO global pharmacovigilance database up to January 2024, to evaluate maternal–fetal outcomes associated with breast cancer (BC ...
Rayan Kabirian +12 more
wiley +1 more source
Pain is a key determinant of quality‐of‐life following breast cancer surgery, the most common cancer operation in the United States. Gabapentinoids are frequently prescribed for pain management, yet their respiratory, cardiovascular, and opioid‐related adverse effects remain unclear.
Jyun‐Heng Lai +12 more
wiley +1 more source

